Category: Artificial Intelligence

Explore our library of blogs, insights, research papers, and more information on compliance in the life sciences industry.

The CMS Open Payments Program requires life sciences companies to report payments and transfers of value to physicians, teaching hospitals, and other covered recipients to the Centers for Medicare and Medicaid Services (CMS). Out of the several critical aspects of this program, one is adhering to the de minimis rule for reporting spend data. For […]

In the U.S. Life Sciences sector, managing interactions with Healthcare Professionals (HCPs) and Healthcare Organizations (HCOs) is critical for maintaining compliance with regulatory standards and ensuring ethical business practices. The rise of data-driven HCP engagement solutions offers a transformative approach to these interactions, providing robust frameworks for transparency, accountability, and efficiency. This blog delves into […]

The life sciences industry is subject to stringent regulatory requirements and constant scrutiny, making compliance a critical yet challenging aspect of operations. Traditional methods of compliance management, often characterized by manual processes and retrospective audits, are no longer sufficient to keep pace with the dynamic regulatory environment. To overcome such challenges, the integration of Artificial […]

The new era of regulatory enforcement demands companies and compliance teams to stay ahead of the curve by leveraging cutting-edge AI technologies designed to identify, manage, and mitigate risks while assuring compliance. One such technology that is making significant strides in making access to data as convenient as possible is chatbots powered by generative AI, […]

“48% of compliance teams are turning to big data and analytics to strengthen their compliance function.” (Source: Compliance Risk Study – 2022 | Accenture) Data forms the foundation of every successful compliance program. This fundamental concept is straightforward: Companies develop success metrics backed by data to assess the effectiveness of their compliance efforts. Life sciences […]

Commercial compliance programs serve as the foundation of organizational integrity, ensuring adherence to all applicable rules and regulations specifically related to the company’s commercial activities. From the U.S. Department of Justice (DOJ) compliance mandates to the Office of Inspector General’s (OIG) enforcement-centric stance on third-party engagements, commercial compliance programs are designed not just for regulatory reporting but for […]